PSYREFLECT

Issue #72

September 10, 2026

#1Research

A Vagus Nerve Pilot Reaches Past Depression, Without a Sham Arm

The autonomic-symptom score cleared statistical correction. The PTSD-symptom score, the study's only psychiatric measure, did not.

vagus nerve stimulationtaVNSlong COVIDPTSD
2 minRead analysis
#2Research

Individualized fMRI-Guided TMS Target Speeds Antidepressant Response in Resistant Depression

A personalized fMRI target got patients to a significant improvement on session 10; the standard target got them to the same statistical finish line on session 20 – and by the end, the two lines met.

TMStreatment-resistant depressionneuronavigationresting-state fMRI
3 minRead analysis
#3Tool

After Two Failed Antidepressants, a Dutch Trial Pits rTMS Against the Next Drug

At the same threshold of treatment resistance, 27.1% of patients assigned to rTMS reached remission at 8 weeks, versus 4.9% assigned to the next step in the medication algorithm.

rTMStreatment-resistant depressiontreatment algorithmDLPFC stimulation
3 minRead analysis
#4Industry

China's First Class III TMS Certificate Names One Diagnosis, Not a Modality

Twenty-eight of the twenty-nine TMS devices previously cleared in China held a lower-risk classification than the psychiatric use they were sold for.

TMSChinamedical device regulationNMPA
3 minRead analysis
#5Industry

Five FDA-Cleared Uses, Fourteen Marketed Ones

"Miraculous results" – marketing language from a clinic website selling MeRT for autism, quoted in the letter as an example of a claim the published evidence does not support, not a conclusion by the letter's own authors.

TMSoff-label marketingautism spectrum disorderFDA clearance
3 minRead analysis
#6Resource

The Checklist a UK ECT Team Is Measured Against

To achieve accreditation, a team must meet 100% of type 1 standards, 80% of type 2 standards, and 60% of type 3 standards.

ECTaccreditationclinical standardsRoyal College of Psychiatrists
3 minRead analysis
Issue #72 | PsyReflect